Comparison of effectiveness of injection vitamin D3 with normal saline in patients suffering from warts

Immunotherapy of cutaneous warts: A novel comparative study between intralesional vitamin D3 and normal saline from eastern India

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046217

Enrollment

Registered

2022-10-06

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B079- Viral wart, unspecified

Interventions

Intervention1: Vitamin D3: Intralesional Vitamin D3 injection dose-1 ml cpntaining 60,000 IU, Freq- every monthly, Duration- 4 month Control Intervention1: Normal Saline: Intralesional NORMAL SALINE I

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients with multiple warts who are willing to participate in the study through an informed consent.

Exclusion criteria

Exclusion criteria: Patients with multiple warts not willing to participate in the study. Patients with single wart. Pregnant and lactating patients with multiple warts. Patients with multiple warts but aged Immunocompromised patients with multiple warts. Patients with mucosal, facial or anogenital warts. Patients with severe cardiac or respiratory comorbidities.

Design outcomes

Primary

Measure	Time frame
Reduction in number and size of the local and distant warts.Timepoint: Baseline, 4 week, 8 week, 12 week, 16 week, 20 week, 24 week, 28 week, 32 week	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactSaubhagya Chowdhury

IPGME&R AND SSKM Hospital

chatterjee.gobinda@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026